Á lódáil...
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease
BACKGROUND: Angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor antagonists (AIIRA) are considered to be equally effective for patients with diabetic kidney disease (DKD), but renal and not mortality outcomes have usually been considered. OBJECTIVES: To evaluate the benefits...
Na minha lista:
| Foilsithe in: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
John Wiley & Sons, Ltd
2006
|
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6956646/ https://ncbi.nlm.nih.gov/pubmed/17054288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006257 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|